Main Session
Sep
29
PQA 06 - PQA 06: Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement
3726 - WGS-Based Personalized ctDNA Assay for Molecular Residual Disease (MRD) Detection in Locally Advanced Cervical Cancer Treated with Definitive Chemoradiotherapy: Interim Results from a Prospective Multicenter Study (MONSTAR-SCREEN-3)
Presenter(s)
Masaki Nakamura, MD - Kobe Minimally invasive Cancer Center, Kobe, Hyogo